GKOS Glaukos Corp

$180.41 +0.52%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Glaukos Corp (GKOS) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $10.6 billion. Shares last traded at $180.41, 6.1% below their 52-week high. Over the past year the stock is up 91.0%. Net profit margin is -30.7%, below the peer median of -9.3%. Revenue grew 32.3% year over year.

Market Cap

$10.6B

Shares Out

59.0M

EPS (TTM)

$-2.60

P/E Ratio

—

P/S Ratio

17.36

P/B Ratio

15.59

Dividend / Share

—

Dividend Yield

—

52-Week High

$192.14

52-Week Low

$73.60

Volume

40,423

Avg Vol (3m)

56,843.841

Performance

-0.82%

+5.52%

+48.28%

+60.97%

YTD

+62.82%

+90.95%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

56.99

SMA (50)

$165.97

SMA (200)

$128.83

Price vs SMA50

+8.70%

Price vs SMA200

+40.03%

ATR (14)

$6.96

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$613M

Net Income

$-188M

Gross Margin

60.7%

Operating Margin

-31.6%

Net Margin

-30.7%

Return on Equity

-27.6%

Return on Assets

-20.4%

Current Ratio

5.04

Debt / Equity

0.00

Revenue Growth (YoY)

+32.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.65	2026-07-29
Q1 2026	$-0.34	2026-04-30
FY 2025	$-3.28	2026-02-23
Q3 2025	$-0.95	2025-10-31
Q2 2026	$-0.66	2026-07-29
Q1 2026	$-0.32	2026-04-30

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

GKOS vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/S vs peers

17.36 / 2.94 med

+491% premium

Net margin vs peers

-30.7% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.